A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Breast cancer risk is partially determined by several hormone-related factors. Preclinical and clinical studies suggested that resveratrol may modulate these hormonal factors. METHODS: We conducted a pilot study in postmenopausal women with high body mass index (BMI ≥ 25 kg/m2) to determine the clinical effect of resveratrol on systemic sex steroid hormones. Forty subjects initiated the resveratrol intervention (1 gm daily for 12 weeks) with six withdrawn early due to adverse events (AEs). Thirty-four subjects completed the intervention. RESULTS: Resveratrol intervention did not result in significant changes in serum concentrations of estradiol, estrone, and testosterone but led to an average of 10% increase in the concentrations of sex steroid hormone binding globulin (SHBG). Resveratrol intervention resulted in an average of 73% increase in urinary 2-hydroxyestrone (2-OHE1) levels leading to a favorable change in urinary 2-OHE1/16α-OHE1 ratio. One participant had asymptomatic Grade 4 elevation of liver enzymes at the end of study intervention. Two subjects had Grade 3 skin rashes. The remaining adverse events were Grade 1 or 2 events. The most common adverse events were diarrhea and increased total cholesterol, reported in 30% and 27.5% of the subjects, respectively. CONCLUSION: We conclude that among overweight and obese postmenopausal women, daily 1 gm dose of resveratrol has favorable effects on estrogen metabolism and SHBG. Further placebo-controlled studies are needed to confirm our findings on these hormone-related breast cancer risk factors and the attribution of the adverse effects observed in the study population. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01370889.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women
Endogenous Hormones Breast Cancer Collaborative Group (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg022 · Cited by 1,093 · cited 1×
“Postmenopausal women with high adiposity produce elevated levels of estrogens, a mechanism thought to link high adiposity with breast cancer [1-5].”
BackgroundSödergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080 · cited 1×
“We calculated the hormone fractions based on the law of mass action [29] and found that resveratrol intervention did”
MethodLukanova, A., Lundin, E., Zeleniuch-Jacquotte, A., Muti, P., Mure, A., Rinaldi, S., Dossus, L., Micheli, A., Arslan, A., Lenner, P., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500161 · Cited by 315 · cited 2×
“Postmenopausal women with high adiposity produce elevated levels of estrogens, a mechanism thought to link high adiposity with breast cancer [1-5].”
BackgroundZhu, B. T., Han, G.-Z., Shim, J.-Y., Wen, Y., & Jiang, X.-R. (2006) · Endocrinology · doi:10.1210/en.2006-0113 · Cited by 271
Moal, V., Mathieu, E., Reynier, P., Malthièry, Y., & Gallois, Y. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.07.013 · Cited by 154 · cited 1×
“Serum testosterone concentrations were measured by a sensitive and specific liquid chromatographytandem mass spectrometry assay [24] with minor modifications to improve assay specificity.”
Method
Cited by
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
AKT as a Therapeutic Target for Cancer
Song, M., Bode, A. M., Dong, Z., & Lee, M.-H. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2738 · Cited by 782
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Resveratrol for cancer therapy: Challenges and future perspectives
Ren, B., Kwah, M. X.-Y., Liu, C., Ma, Z., Shanmugam, M. K., Ding, L., Xiang, X., Ho, P. C.-L., Wang, L., Ong, P. S., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.001 · Cited by 495
Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?
Weiskirchen, S., & Weiskirchen, R. (2016) · Advances in Nutrition · doi:10.3945/an.115.011627 · Cited by 306
Metadata
- Authors
- Chow, H.-H. S., Garland, L. L., Heckman-Stoddard, B. M., Hsu, C.-H., Butler, V. D., Cordova, C. A., Chew, W. M., & Cornelison, T. L.
- Venue
- Journal of Translational Medicine
- Published
- 2014-08-14
- Volume
- 12
- Issue
- 1
- Pages
- 223-223
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2098981439
- Cited by
- 92
- References
- 5
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. https://app.cochat.ai/papers/10.1186/s12967-014-0223-0
- The paper
- Chow, H.-H. S., Garland, L. L., Heckman-Stoddard, B. M., Hsu, C.-H., Butler, V. D., Cordova, C. A., Chew, W. M., & Cornelison, T. L. (2014). A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones. Journal of Translational Medicine. https://doi.org/10.1186/s12967-014-0223-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.